Jan 7: NYC: Biggest blizzard since 1947. Jan 18: Baltimore activist Garey Lambert dies of AIDS; Lynda Dee is there. Jan 25: Spencer Cox at meeting with FDA Commissioner David Kessler in Rockville on protease inhibitors. Jan 31: Mark Harrington…
Jan 20: Bill Clinton's second inaugural. Michael Marco and Mark Harrington finish initial draft of OI Report. Jan 22: Crisis at Retrovirus re: on-site registration for Linda Grinberg and sixteen other unregistered community members. They are not allowed in. (Relations…
Commune of Shell Shocked Soldiers Springs Up Then Quickly Crumbles, Inexplicably By David Barr Radioactive Reindeer "In Stockholm the bags were a bright blue." Thus begins David Barr's quirky personal account of the dozen or so international AIDS conferences which…
Series of Superinfection Reports Leave Researchers Debating Not "If" but "How" -- And What It All Means By Richard Jefferys "Extrapolating Implications" The possibility of multiple HIV infections in a given individual has concerned both people living with HIV and…
By Richard Jefferys A Patient With HIV-1 Superinfection New England Journal of Medicine, September 5, 2002, (Stephanie Jost, et al.) A case report involving one 38 year old male, initially diagnosed with acute HIV infection in November 1998. At that…
Philly ACT UPer and Health Gap Founder Tackles the Challenges of an Aging Activist Movement "Recreating the Funnel" Among the numerous hackneyed saws of activism, a front-runner for the most obviously true and often most objectively impossible is, "We need…
Disco Queen Née Policy Gadfly Recalls Decade of Seismic Shifts in Clinical Landscape By Lynda Dee Revolution of Pragmatism As doting friend, renegade attorney and seasoned circuit goer, Lynda Dee sometimes seems to have made a life out of rescuing…
As Scale Up to Rx for 3M by 2005 Proceeds, Activist Groups Worldwide Begin to Lay Groundwork By Mark Harrington Educating Patients, Providers At the Barcelona AIDS conference this summer, TAG co-sponsored the first meeting of a new global coalition…
Consensus Statement in Opposition to Licensure of Remune As Monotherapy for HIV Infection in Thailand "Without a large burden for past research and development ... and based on a minimum gross profit of $75 per dose of Remune sold ..…
HIV Spread Threatens Decade's Tuberculosis Treatment/Prevention Success By Daniel Raymond New Challenges, Questions TB researchers and policy-makers from around the world gathered on 3-5 June 2002 in Washington, D.C., at the 4th World TB Congress (the 3rd was held ten…